Search Results - "Sulica, Roxana"

Long-term impact of add-on sequential triple combination therapy in pulmonary arterial hypertension: real world experience by Deshwal, Himanshu, Weinstein, Tatiana, Salyer, Rachel, Thompson, Jesse, Cefali, Frank, Fenton, Rebecca, Bondarsky, Eric, Sulica, Roxana

“…Background: Sequential triple combination therapy is recommended for pulmonary arterial hypertension (PAH) patients who are not at therapeutic goal on dual…”
Get full text

COVID-19 in Pulmonary Artery Hypertension (PAH) Patients: Observations from a Large PAH Center in New York City by Sulica, Roxana, Cefali, Frank, Motschwiller, Caroline, Fenton, Rebecca, Barroso, Anabela, Sterman, Daniel

“…Information on outcomes of COVID-19 in pulmonary arterial hypertension (PAH) patients is limited to a few case series and surveys. Here, we describe our…”
Get full text

Clinical and hemodynamic benefit of macitentan and riociguat upfront combination in patients with pulmonary arterial hypertension by Sulica, Roxana, Sangli, Swathi, Chakravarti, Aloke, Steiger, David

“…In this open-label study, we evaluated the effect of upfront macitentan and riociguat combination in newly diagnosed pulmonary arterial hypertension (PAH)…”
Get full text

Exercise-induced pulmonary hypertension by stress echocardiography: Prevalence and correlation with right heart hemodynamics by Misra, Deepika, MD, Kendes, Ante, Sulica, Roxana, MD, Carabello, Blase, MD

“…Abstract Objectives The aim of this study was to determine the prevalence of exercise-induced pulmonary hypertension (EIPH) in consecutive subjects referred…”
Get full text

6-Minute Walk Distance and Mean Pulmonary Artery Pressure in Pulmonary Hypertension by Nesheim, David, MD, Ramesh, Navitha, MD, Filopei, Jason, MD, Sulica, Roxana, MD

Get full text

Pulmonary Vasodilator Therapy in Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (Severe PH-COPD): A Systematic Review and Meta-Analysis by Elkhapery, Ahmed, Hammami, M Bakri, Sulica, Roxana, Boppana, Hemanth, Abdalla, Zeinab, Iyer, Charoo, Taifour, Hazem, Niu, Chengu, Deshwal, Himanshu

“…Chronic obstructive pulmonary disease-associated pulmonary hypertension (PH-COPD) results in a significant impact on symptoms, quality of life, and survival…”
Get full text

Pulmonary Arterial Hypertension- 4 Causes, 1 Patient by Ramesh, Navitha, MD, Nesheim, David, MD, Filopei, Jason, MD, Sulica, Roxana, MD

Get full text

Limited at Birth: Complications of Congenital Pulmonary Anomalies by Ramesh, Navitha, MD, Deseda, Jaime, MD, Mercader, Mariana, MD, Filopei, Jason, MD, Sulica, Roxana, MD

Get full text

Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension by Sulica, Roxana, Teirstein, Alvin S, Kakarla, Shudhir, Nemani, Nimish, Behnegar, Anousheh, Padilla, Maria L

“…To differentiate the clinical, radiographic, and physiologic profile in patients with sarcoidosis with and without pulmonary hypertension. Retrospective…”
Get more information

Prevalence and Correlates of Septal Delayed Contrast Enhancement in Patients With Pulmonary Hypertension by Sanz, Javier, MD, Dellegrottaglie, Santo, MD, Kariisa, Mbabazi, MPH, Sulica, Roxana, MD, Poon, Michael, MD, O’Donnell, Thomas P., PhD, Mehta, Davendra, MD, PhD, Fuster, Valentin, MD, PhD, Rajagopalan, Sanjay, MD

“…Using cardiac magnetic resonance, the presence of myocardial delayed contrast enhancement (DCE) has been described in the ventricular septum at the level of…”
Get full text

Poppers Not Only Make You High: A Rare Case of Amyl Nitrate-Induced Hypoxia by Olazagasti, Coral, MD, Paralkar, Janvi, MD, Vishnevetsky, Michael, MD, Chakravarti, Aloke, MD, Sulica, Roxana, MD, Favila, Kristine, DO

Get full text

Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center by Sulica, Roxana, Fenton, Rebecca, Cefali, Frank

“…Introduction Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are rare, life-threatening diseases in which…”
Get full text

Diffusing Lung Capacity Reveals Phenotypical Complexity in Pulmonary Hypertension by Ramesh, Navitha, MD, Nesheim, David, MD, Lau, Michael, MD, Filopei, Jason, MD, Bergman, Michael, MD, Thomas, Sarun, DO, Sulica, Roxana, MD, Miller, Albert, MD

Get full text

Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat by Rahaghi, Franck F., Balasubramanian, Vijay P., Bourge, Robert C., Burger, Charles D., Chakinala, Murali M., Eggert, Michael S., Elwing, Jean M., Feldman, Jeremy, King, Christopher, Klinger, James R., Mathai, Stephen C., McConnell, John Wesley, Palevsky, Harold I., Restrepo‐Jaramillo, Ricardo, Safdar, Zeenat, Sager, Jeffrey S., Sood, Namita, Sulica, Roxana, White, R. James, Hill, Nicholas S.

“…Dual combination therapy with a phosphodiesterase‐5 inhibitor (PDE5i) and endothelin receptor antagonist is recommended for most patients with…”
Get full text

Pulmonary Hypertension Due to Common Respiratory Conditions: Classification, Evaluation and Management Strategies by Fein, Daniel G, Zaidi, Ali N, Sulica, Roxana

“…Pulmonary hypertension (PH) due to chronic respiratory disease and/or hypoxia is classified as World Health Organization (WHO) Group III pulmonary…”
Get full text

Approach to the hospitalized patient with pulmonary arterial hypertension by Deshwal, Himanshu, Sulica, Roxana

“…Hospitalization in pulmonary arterial hypertension (PAH) patients is an important clinical worsening event significantly associated with subsequent mortality…”
Get full text

LESSONS LEARNED FROM TRIPLE COMBINATION THERAPY IN PULMONARY ARTERIAL HYPERTENSION by Schuster, Sheeja, Sulica, Roxana

Get full text

COMPARISON OF BASELINE CLINICAL CHARACTERISTICS AND INVASIVE HEMODYNAMIC DATA OF NEWLY DIAGNOSED PULMONARY ARTERIAL HYPERTENSION PATIENTS WITH TYPICAL VERSUS ATYPICAL FEATURES by BENES, LINDA, MAJHU, KABEER, SULICA, ROXANA

Get full text

LESSONS LEARNED FROM STARTING A MULTIDISCIPLINARY CTEPH (CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION) PROGRAM AT A TERTIARY CARE HOSPITAL IN NEW YORK CITY by MOTSCHWILLER, CAROLINE, SULICA, ROXANA, CHAN, JUSTIN

Get full text

Advances in the management of pulmonary arterial hypertension by Deshwal, Himanshu, Weinstein, Tatiana, Sulica, Roxana

“…The management of pulmonary arterial hypertension (PAH) has significantly evolved over the last decades in the wake of more sensitive diagnostics and…”
Get full text